CN Stock MarketDetailed Quotes

Yabao Pharmaceutical Group (600351)

Watchlist
  • 6.62
  • -0.14-2.07%
Not Open May 14 15:00 CST
4.58BMarket Cap14.33P/E (TTM)

Yabao Pharmaceutical Group (600351) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
-6.92%572.02M
-16.60%2.24B
-19.46%1.71B
-21.08%1.14B
-20.32%614.53M
-7.69%2.69B
-3.54%2.12B
-5.82%1.44B
-3.66%771.21M
7.05%2.91B
Operating revenue
-6.92%572.02M
-16.60%2.24B
-19.46%1.71B
-21.08%1.14B
-20.32%614.53M
-7.69%2.69B
-3.54%2.12B
-5.82%1.44B
-3.66%771.21M
7.05%2.91B
Other operating revenue
----
-13.01%30.03M
----
13.06%15.51M
----
17.18%34.52M
----
-32.37%13.72M
----
-21.34%29.46M
Total operating cost
-9.05%446.34M
-20.14%1.91B
-23.33%1.42B
-24.24%944.32M
-23.87%490.74M
-8.75%2.39B
-6.04%1.85B
-7.44%1.25B
-4.76%644.62M
3.20%2.62B
Operating cost
-7.54%267.45M
-18.03%1.06B
-20.10%817.88M
-18.09%540.59M
-14.00%289.26M
5.83%1.3B
7.88%1.02B
0.69%659.98M
1.68%336.34M
2.25%1.23B
Operating tax surcharges
-7.10%8.2M
0.63%34.26M
0.11%26.6M
-6.04%17.29M
-12.19%8.83M
-3.52%34.05M
-4.29%26.57M
-4.53%18.4M
2.25%10.06M
3.91%35.29M
Operating expense
-7.45%103.58M
-31.74%451.8M
-36.39%327.46M
-40.20%222.15M
-44.22%111.91M
-31.89%661.87M
-27.57%514.82M
-23.53%371.48M
-15.97%200.64M
8.27%971.69M
Administration expense
-17.29%49.12M
-5.02%246.05M
-10.01%180.39M
-8.45%116.73M
-11.03%59.38M
-2.57%259.07M
0.95%200.46M
-2.42%127.51M
-1.79%66.75M
-0.50%265.91M
Financial expense
-70.91%-360.41K
-290.18%-3.18M
-463.64%-2.51M
-851.97%-970.09K
-16.36%-210.88K
-125.25%-813.97K
-112.00%-445.93K
-96.37%129.01K
-108.05%-181.24K
-70.23%3.22M
-Interest expense (Financial expense)
-70.84%187.91K
-72.78%1.46M
-76.46%1.1M
-66.66%1.21M
-64.87%644.48K
-56.52%5.35M
-56.58%4.66M
-56.78%3.62M
-55.33%1.83M
-34.47%12.3M
-Interest Income (Financial expense)
20.97%-705.05K
22.25%-5.01M
27.08%-3.87M
35.24%-2.35M
56.68%-892.13K
32.03%-6.45M
27.28%-5.31M
27.30%-3.63M
-1.35%-2.06M
-16.01%-9.49M
Research and development
-14.92%18.35M
-15.95%117.27M
-19.60%72.29M
-29.56%48.54M
-30.46%21.57M
17.95%139.52M
6.32%89.91M
33.02%68.9M
13.75%31.01M
-9.44%118.29M
Credit Impairment Loss
110.90%303.32K
70.29%8.3M
669.65%10.49M
709.01%7.49M
-233.08%-2.78M
135.35%4.88M
-23.92%1.36M
71.75%-1.23M
-58.44%-835.84K
125.77%2.07M
Asset Impairment Loss
144.38%1.37M
-98.23%-83.58M
-875.53%-66.4M
-67.16%-10.01M
-1,215.20%-3.1M
55.03%-42.16M
-524.69%-6.81M
-338.99%-5.99M
65.53%-235.38K
-37.75%-93.75M
Other net revenue
-128.83%-1.31M
647.14%40.78M
-252.92%-33.35M
13.96%16.93M
-56.18%4.53M
108.71%5.46M
8.51%21.81M
173.79%14.86M
50.94%10.34M
-13.78%-62.69M
Fair value change income
-3,205.31%-14.06M
767.41%19M
937.25%1.09M
1,142.15%419.74K
6,813.64%452.81K
-10.28%-2.85M
4,784.89%104.65K
131.57%33.79K
98.54%-6.74K
27.09%-2.58M
Invest income
49.73%903.96K
39,405.18%74.04M
1,794.24%1.56M
633.66%992.78K
169.82%603.72K
93.18%-188.37K
103.87%82.21K
108.77%135.32K
153.57%223.75K
-337.80%-2.76M
-Including: Investment income associates
-3.98%-100.96K
2,939.42%9.11M
-34.09%-305.8K
-57.44%-203.87K
2.75%-97.09K
22.08%-320.74K
24.55%-228.05K
37.33%-129.49K
-1.41%-99.84K
-9.63%-411.63K
Asset deal income
----
-47.28%182.99K
-60.12%70.09K
-10.98%50.19K
59,984.28%26.61K
-69.06%347.09K
-81.89%175.75K
-94.04%56.38K
-100.00%44.28
866.42%1.12M
Other revenue
9.07%10.17M
-49.76%22.83M
-26.19%19.85M
-17.66%17.99M
-16.68%9.33M
36.80%45.43M
30.84%26.89M
84.46%21.85M
39.34%11.19M
32.53%33.21M
Operating profit
-3.08%124.38M
23.63%370.84M
-12.18%253.26M
-0.06%212.02M
-6.29%128.32M
32.53%299.95M
17.56%288.37M
10.64%212.14M
4.94%136.94M
83.20%226.34M
Add:Non operating Income
-29.77%433.04K
335.58%7.12M
183.82%3.29M
10.61%1.14M
8.16%616.58K
-44.67%1.63M
0.14%1.16M
62.33%1.03M
253.23%570.04K
-48.43%2.95M
Less:Non operating expense
-91.15%56.02K
-63.06%3.5M
-42.33%3.18M
98.44%729.08K
423.61%633.17K
-8.04%9.48M
237.30%5.52M
-58.99%367.4K
-82.68%120.92K
184.04%10.31M
Total profit
-2.77%124.75M
28.19%374.46M
-10.79%253.36M
-0.18%212.43M
-6.61%128.31M
33.39%292.11M
16.01%284.01M
11.14%212.81M
5.72%137.39M
74.28%218.98M
Less:Income tax cost
-20.04%17.78M
9.33%74.56M
-1.21%54.87M
-0.99%37.24M
-19.48%22.24M
74.55%68.19M
71.89%55.54M
51.11%37.61M
28.86%27.62M
85.65%39.07M
Net profit
0.85%106.97M
33.93%299.9M
-13.12%198.49M
-0.00%175.19M
-3.37%106.07M
24.46%223.92M
7.51%228.47M
5.16%175.19M
1.14%109.77M
71.99%179.91M
Net profit from continuing operation
0.85%106.97M
33.93%299.9M
-13.12%198.49M
-0.00%175.19M
-3.37%106.07M
24.46%223.92M
7.51%228.47M
5.16%175.19M
1.14%109.77M
71.99%179.91M
Less:Minority Profit
125.88%310.73K
-7.14%-20.11M
-156.80%-16.6M
117.26%791.18K
51.82%-1.2M
4.57%-18.77M
-391.87%-6.47M
-219.32%-4.58M
-324.59%-2.49M
-38,649.35%-19.67M
Net profit of parent company owners
-0.57%106.66M
31.86%320.01M
-8.44%215.09M
-2.99%174.4M
-4.45%107.27M
21.60%242.69M
9.88%234.93M
6.99%179.77M
4.51%112.26M
90.71%199.59M
Earning per share
Basic earning per share
1.25%0.1541
35.29%0.46
-5.40%0.3066
0.44%0.2483
-0.39%0.1522
30.77%0.34
16.08%0.3241
13.29%0.2472
9.53%0.1528
85.71%0.26
Other composite income
-145.29%-3.16M
70.72%-1.29M
-10,199.39%-4.4M
Other composite income of parent company owners
----
-145.29%-3.16M
----
----
----
70.72%-1.29M
----
----
----
-10,199.39%-4.4M
Total composite income
0.85%106.97M
33.29%296.74M
-13.12%198.49M
-0.00%175.19M
-3.37%106.07M
26.84%222.63M
7.56%228.47M
5.16%175.19M
1.16%109.77M
67.72%175.51M
Total composite income of parent company owners
-0.57%106.66M
31.26%316.85M
-8.44%215.09M
-2.99%174.4M
-4.45%107.27M
23.68%241.4M
9.93%234.93M
6.99%179.77M
4.52%112.26M
86.42%195.18M
Total composite income of minority owners
125.88%310.73K
-7.14%-20.11M
-156.80%-16.6M
117.26%791.18K
51.82%-1.2M
4.57%-18.77M
-391.87%-6.47M
-219.32%-4.58M
-324.59%-2.49M
-38,649.35%-19.67M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
PwC China (Special General Partnership)
--
--
--
PwC China (Special General Partnership)
--
--
--
PwC China (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue -6.92%572.02M-16.60%2.24B-19.46%1.71B-21.08%1.14B-20.32%614.53M-7.69%2.69B-3.54%2.12B-5.82%1.44B-3.66%771.21M7.05%2.91B
Operating revenue -6.92%572.02M-16.60%2.24B-19.46%1.71B-21.08%1.14B-20.32%614.53M-7.69%2.69B-3.54%2.12B-5.82%1.44B-3.66%771.21M7.05%2.91B
Other operating revenue -----13.01%30.03M----13.06%15.51M----17.18%34.52M-----32.37%13.72M-----21.34%29.46M
Total operating cost -9.05%446.34M-20.14%1.91B-23.33%1.42B-24.24%944.32M-23.87%490.74M-8.75%2.39B-6.04%1.85B-7.44%1.25B-4.76%644.62M3.20%2.62B
Operating cost -7.54%267.45M-18.03%1.06B-20.10%817.88M-18.09%540.59M-14.00%289.26M5.83%1.3B7.88%1.02B0.69%659.98M1.68%336.34M2.25%1.23B
Operating tax surcharges -7.10%8.2M0.63%34.26M0.11%26.6M-6.04%17.29M-12.19%8.83M-3.52%34.05M-4.29%26.57M-4.53%18.4M2.25%10.06M3.91%35.29M
Operating expense -7.45%103.58M-31.74%451.8M-36.39%327.46M-40.20%222.15M-44.22%111.91M-31.89%661.87M-27.57%514.82M-23.53%371.48M-15.97%200.64M8.27%971.69M
Administration expense -17.29%49.12M-5.02%246.05M-10.01%180.39M-8.45%116.73M-11.03%59.38M-2.57%259.07M0.95%200.46M-2.42%127.51M-1.79%66.75M-0.50%265.91M
Financial expense -70.91%-360.41K-290.18%-3.18M-463.64%-2.51M-851.97%-970.09K-16.36%-210.88K-125.25%-813.97K-112.00%-445.93K-96.37%129.01K-108.05%-181.24K-70.23%3.22M
-Interest expense (Financial expense) -70.84%187.91K-72.78%1.46M-76.46%1.1M-66.66%1.21M-64.87%644.48K-56.52%5.35M-56.58%4.66M-56.78%3.62M-55.33%1.83M-34.47%12.3M
-Interest Income (Financial expense) 20.97%-705.05K22.25%-5.01M27.08%-3.87M35.24%-2.35M56.68%-892.13K32.03%-6.45M27.28%-5.31M27.30%-3.63M-1.35%-2.06M-16.01%-9.49M
Research and development -14.92%18.35M-15.95%117.27M-19.60%72.29M-29.56%48.54M-30.46%21.57M17.95%139.52M6.32%89.91M33.02%68.9M13.75%31.01M-9.44%118.29M
Credit Impairment Loss 110.90%303.32K70.29%8.3M669.65%10.49M709.01%7.49M-233.08%-2.78M135.35%4.88M-23.92%1.36M71.75%-1.23M-58.44%-835.84K125.77%2.07M
Asset Impairment Loss 144.38%1.37M-98.23%-83.58M-875.53%-66.4M-67.16%-10.01M-1,215.20%-3.1M55.03%-42.16M-524.69%-6.81M-338.99%-5.99M65.53%-235.38K-37.75%-93.75M
Other net revenue -128.83%-1.31M647.14%40.78M-252.92%-33.35M13.96%16.93M-56.18%4.53M108.71%5.46M8.51%21.81M173.79%14.86M50.94%10.34M-13.78%-62.69M
Fair value change income -3,205.31%-14.06M767.41%19M937.25%1.09M1,142.15%419.74K6,813.64%452.81K-10.28%-2.85M4,784.89%104.65K131.57%33.79K98.54%-6.74K27.09%-2.58M
Invest income 49.73%903.96K39,405.18%74.04M1,794.24%1.56M633.66%992.78K169.82%603.72K93.18%-188.37K103.87%82.21K108.77%135.32K153.57%223.75K-337.80%-2.76M
-Including: Investment income associates -3.98%-100.96K2,939.42%9.11M-34.09%-305.8K-57.44%-203.87K2.75%-97.09K22.08%-320.74K24.55%-228.05K37.33%-129.49K-1.41%-99.84K-9.63%-411.63K
Asset deal income -----47.28%182.99K-60.12%70.09K-10.98%50.19K59,984.28%26.61K-69.06%347.09K-81.89%175.75K-94.04%56.38K-100.00%44.28866.42%1.12M
Other revenue 9.07%10.17M-49.76%22.83M-26.19%19.85M-17.66%17.99M-16.68%9.33M36.80%45.43M30.84%26.89M84.46%21.85M39.34%11.19M32.53%33.21M
Operating profit -3.08%124.38M23.63%370.84M-12.18%253.26M-0.06%212.02M-6.29%128.32M32.53%299.95M17.56%288.37M10.64%212.14M4.94%136.94M83.20%226.34M
Add:Non operating Income -29.77%433.04K335.58%7.12M183.82%3.29M10.61%1.14M8.16%616.58K-44.67%1.63M0.14%1.16M62.33%1.03M253.23%570.04K-48.43%2.95M
Less:Non operating expense -91.15%56.02K-63.06%3.5M-42.33%3.18M98.44%729.08K423.61%633.17K-8.04%9.48M237.30%5.52M-58.99%367.4K-82.68%120.92K184.04%10.31M
Total profit -2.77%124.75M28.19%374.46M-10.79%253.36M-0.18%212.43M-6.61%128.31M33.39%292.11M16.01%284.01M11.14%212.81M5.72%137.39M74.28%218.98M
Less:Income tax cost -20.04%17.78M9.33%74.56M-1.21%54.87M-0.99%37.24M-19.48%22.24M74.55%68.19M71.89%55.54M51.11%37.61M28.86%27.62M85.65%39.07M
Net profit 0.85%106.97M33.93%299.9M-13.12%198.49M-0.00%175.19M-3.37%106.07M24.46%223.92M7.51%228.47M5.16%175.19M1.14%109.77M71.99%179.91M
Net profit from continuing operation 0.85%106.97M33.93%299.9M-13.12%198.49M-0.00%175.19M-3.37%106.07M24.46%223.92M7.51%228.47M5.16%175.19M1.14%109.77M71.99%179.91M
Less:Minority Profit 125.88%310.73K-7.14%-20.11M-156.80%-16.6M117.26%791.18K51.82%-1.2M4.57%-18.77M-391.87%-6.47M-219.32%-4.58M-324.59%-2.49M-38,649.35%-19.67M
Net profit of parent company owners -0.57%106.66M31.86%320.01M-8.44%215.09M-2.99%174.4M-4.45%107.27M21.60%242.69M9.88%234.93M6.99%179.77M4.51%112.26M90.71%199.59M
Earning per share
Basic earning per share 1.25%0.154135.29%0.46-5.40%0.30660.44%0.2483-0.39%0.152230.77%0.3416.08%0.324113.29%0.24729.53%0.152885.71%0.26
Other composite income -145.29%-3.16M70.72%-1.29M-10,199.39%-4.4M
Other composite income of parent company owners -----145.29%-3.16M------------70.72%-1.29M-------------10,199.39%-4.4M
Total composite income 0.85%106.97M33.29%296.74M-13.12%198.49M-0.00%175.19M-3.37%106.07M26.84%222.63M7.56%228.47M5.16%175.19M1.16%109.77M67.72%175.51M
Total composite income of parent company owners -0.57%106.66M31.26%316.85M-8.44%215.09M-2.99%174.4M-4.45%107.27M23.68%241.4M9.93%234.93M6.99%179.77M4.52%112.26M86.42%195.18M
Total composite income of minority owners 125.88%310.73K-7.14%-20.11M-156.80%-16.6M117.26%791.18K51.82%-1.2M4.57%-18.77M-391.87%-6.47M-219.32%-4.58M-324.59%-2.49M-38,649.35%-19.67M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --PwC China (Special General Partnership)------PwC China (Special General Partnership)------PwC China (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More